AbbVie (ABBV) Interest Coverage Ratio (2012 - 2026)
AbbVie (ABBV) posted quarterly Interest Coverage Ratio of 5.56 for Q1 2026, up 4.35% year-over-year from 5.33 in Q1 2025, and down 12.56% quarter-over-quarter from 6.36 in Q4 2025.
AbbVie (ABBV) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Interest Coverage Ratio for 15 consecutive years, with 5.56 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 4.35% year-over-year to 5.56; the TTM figure through Mar 2026 stood at 5.27 (up 49.14% YoY), while the FY2025 annual figure was 1.0, up 62.85% from the prior year.
- Interest Coverage Ratio slipped to 5.56 in Q1 2026 per ABBV's latest filing, from 6.36 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 8.61 in Q1 2022 and bottomed at 2.11 in Q4 2024.
- Historically, Interest Coverage Ratio has averaged 5.37 across 5 years, with a median of 5.56 in 2026.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio slumped 137.31% — and 2025, when it soared 401.12%.
- AbbVie's Interest Coverage Ratio stood at 6.24 in 2022, then decreased by 9.19% to 5.66 in 2023, then plunged by 137.31% to 2.11 in 2024, then soared by 401.12% to 6.36 in 2025, then slipped by 12.56% to 5.56 in 2026.
- Business Quant data shows ABBV's Interest Coverage Ratio at 5.56 in Q1 2026, 6.36 in Q4 2025, and 2.58 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | - |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | -2.64 |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | -50.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.62 |
| Mar 31, 2026 | 5.56 |
| Dec 31, 2025 | 6.36 |
| Sep 30, 2025 | 2.58 |
| Jun 30, 2025 | 6.61 |
| Mar 31, 2025 | 5.33 |
| Dec 31, 2024 | -2.11 |
| Sep 30, 2024 | 5.32 |
| Jun 30, 2024 | 5.51 |
| Mar 31, 2024 | 4.24 |
| Dec 31, 2023 | 5.66 |
| Sep 30, 2023 | 4.11 |
| Jun 30, 2023 | 8.18 |
| Mar 31, 2023 | 5.01 |
| Dec 31, 2022 | 6.24 |
| Sep 30, 2022 | 8.22 |
| Jun 30, 2022 | 5.93 |
| Mar 31, 2022 | 8.61 |
| Dec 31, 2021 | 8.75 |
| Sep 30, 2021 | 7.22 |